BAX and neoplasm: 3.2. Low Dose CTX Combination of Oral MAA Decreased Tumor Growth through Bax Upregulation, Bcl-2 Downregulation, LC3 II Downregulation, Beclin-1 Downregulation and Mitochondrial Injury